IP Library Granted Patent US 11,707,432
Granted Patent B2
US 11,707,432 · App. 16/521,913 · Granted Jul 25, 2023

System and method for controlling the harshness of nicotine-based dry powder formulations

Inventors: Alex Stenzler (Long Beach, CA); Noe Zamel (Toronto, CA); Arthur Slutsky (Toronto, CA); Steven Ellis (Oro-Medonte, CA); Steve Han (Huntington Beach, CA)
Assignee: Philip Morris Products S.A.
A61K9/0075A24F42/20A61K31/465
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,707,432
App. No.
16/521,913
Granted
Jul 25, 2023
Kind
B2
Abstract

A method of controlling or electing the harshness of inhaled nicotine powder formulations is described. The method includes the steps of identifying a concentration of nicotine for a subject to inhale to achieve a desired level of harshness per inhalation, identifying the total dose of nicotine to be inhaled by the subject, and providing the subject with an amount of a formulation comprising nicotine particles having the identified concentration of nicotine, such that the total amount of nicotine particles in the formulation equals the total dose of nicotine.

Claims (23)

1. A method of controlling the harshness of nicotine inhaled by a subject, the method comprising the steps of:

identifying a concentration of nicotine for a dry powder formulation comprising nicotine particles for a subject to inhale based on a desired level of harshness per inhalation, the nicotine particles comprising nicotine salt and sugar;

providing the subject with a first dose comprising a first amount of the formulation having the identified concentration of nicotine;

providing the subject with a second dose comprising a second amount of the formulation, the second dose comprising a lower amount of nicotine than the first dose; and

providing the subject with a third dose comprising a third amount of the formulation, the third dose comprising a lower amount of nicotine than the second dose,

wherein at least one of the second and third doses has a concentration that is higher than the identified concentration of the first dose to increase the harshness of the nicotine inhaled by the subject.

2. The method of claim 1 , wherein the identified concentration of nicotine is selected from concentrations ranging from 0.7 wt-% to 10 wt-%.

3. The method of claim 1 , wherein the method is a method of smoking cessation therapy.

4. The method of claim 1 , wherein the nicotine particles comprise trehalose.

5. The method of claim 1 , wherein the nicotine particles are less than 5 micron in size.

6. The method of claim 1 , wherein the formulation further comprises cough suppressant particles.

7. The method of claim 1 , wherein the formulation is delivered to a subject via a dry powder inhaler.

8. A method of delivering reducing dosages of nicotine to a subject by inhalation, the method comprising:

identifying a first concentration of nicotine for a nicotine dry powder formulation to achieve a desired first level of harshness per inhalation, the nicotine dry powder formulation comprising nicotine particles comprising nicotine salt and sugar;

providing a first dose to the subject, the first dose comprising the nicotine dry powder formulation having the identified first concentration of nicotine;

providing a second dose to the subject, the second dose being lower than the first dose and having a second concentration of nicotine which is greater than the first concentration of nicotine; and

providing a third dose to the subject, the third dose being lower than the second dose and having a third concentration of nicotine which is greater than the second concentration of nicotine.

9. The method of claim 8 , wherein the identified concentration of nicotine is selected from concentrations ranging from 0.7 wt-% to 10 wt-%.

10. The method of claim 8 , wherein the method is a method of smoking cessation therapy.

11. The method of claim 8 , wherein the nicotine particles further comprise trehalose.

12. The method of claim 8 , wherein the nicotine particles are less than 5 micron in size.

13. The method of claim 8 , wherein the formulation further comprises cough suppressant particles.

14. The method of claim 8 , wherein the formulation is delivered to a subject via a dry powder inhaler.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2020
From: SANSA CORPORATION
To: NICO PUFF CORPORATION
Reel/Frame 052353/0260 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2020
From: NICO PUFF CORPORATION
To: PHILIP MORRIS PRODUCTS S.A.
Reel/Frame 052353/0382 →
Continuity (2)
Division 14856116 · Sep 16, 2015
Related Publication 20190343178A1 · Nov 14, 2019